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1. Introduction
Obesity is currently considered as the pandemic of the 21st century and is paradigmatic of
non-transmissible chronic diseases, such as type 2 diabetes mellitus (DM2), cardiovascular
disease and cancer. Thus, due to its extent, obesity is considered a public health problem that
is constantly growing and globally affects both the developed world and developing countries
(WHO Prevalence of Diabetes, 2010). In the United States of America (USA) over 30% of the
adult population is obese, the numbers in Europe are between 15 and 20 % and in Chile, with
a GDP close to $US 20,000 per year, the National Health Survey (Encuesta Nacional de Salud,
ENS) of 2010, showed a total prevalence of obesity of 27.4 %, very similar to industrialized
countries (ENS, 2010).
All epidemiologic studies show that obesity is greater in subjects with low education and less
in individuals with higher education; in Chile, obesity reaches 35% in the former. Additionally,
obesity increases with people's age, reaching its highest level in the group of those between 50
– 64 years. However, it is very important to mention the increase in obesity in children and
adolescents observed in Europe, in Chile and practically throughout the world, and which is
the main cause of the appearance in recent years of a constantly increasing number of type 2
diabetes cases in these age groups (ENS, 2010).
Obesity should be considered as a heterogeneous, multifactorial disease with a genetic base –
more than 60 genes involved have been described – however, predisposition to obesity is not
higher than 30% and environmental factors of individuals and populations account for 70%.
The highest impact factor in the development of obesity is excess food intake and the quality
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of the diet with high contents of carbohydrates and fats, to which sedentary lifestyles and lack
of physical activity are added, both at work and at leisure, a feature common to all populations
nowadays.
Among the causes of obesity, mention should be made of aggressive marketing of non-healthy
foods, the low price of the so-called “junk food”, higher economic income, as well as higher
availability of public transportation and of television sets, video games and internet, all of
which lead to an increase in sedentary lifestyles at all ages. Obesity per se is an independent
risk factor for coronary cardiopathy, whereby it has been included by the American Heart
Association as a major risk factor. Two important investigations, the Framingham and the
Finnish prospective study, confirm the direct association between obesity and coronary
mortality.
Visceral obesity is the main causing factor of metabolic syndrome (MS), which has been defined
as a group of metabolic risk factors (arterial hypertension, dyslipidemia, glucose intolerance),
that are more than randomly interrelated with each other and which directly promote the
development of DM2 and cardiovascular disease (CVD). In the USA, health surveys show a
sustained increase in the prevalence of MS; thus, the National Health and Nutrition Exami‐
nation Survey (NHANES) for 1988 – 94 showed a prevalence of 23.1%, while the same survey
in 1999 – 2006 reported a worrying increase reaching 34%. The Chilean ENS for 2010 reported
very similar figures of 35% (ENS, 2010), while in 2003 it was 22.6%.
Obesity and particularly android or visceral obesity is associated with type 2 diabetes. It should
be highlighted that at diagnosis of DM2, 80% of the subjects are obese. While this is true for
diabetes in general, it should be considered that 90 – 95% of diabetic patients suffer diabetes
type 2 and only 5 to 10% correspond to diabetes type 1, of autoimmune pathogenesis not related
to obesity. In our country, only 1% are type 1 diabetic patients.
There is a universal consensus in that obesity is the leading pathogenic factor of pre-diabetes
and DM2. Obesity is a determinant of insulin resistance (IR) with compensatory hyperinsuli‐
nemia; DM2 becomes manifest when a relative deficiency of insulin secretion is produced.
The International Diabetes Federation estimated a world-wide DM2 prevalence rate of 8.3%
for 2011, which will increase to 9.9% by 2030. Some populations, such as Pima Indians from
the USA or Mexico and people from the Mauritius Islands with rates higher than 20 – 30% are
exceptions. Prevalence is growing explosively, thus the WHO reported that in 2010 there
existed 250,000,000 diabetic patients in the world and most remarkably predicted a figure of
333,000,000 for 2025. The same growth is shown in Chilean investigations, with a progressive
increase from 5.3% in 1981 to 6.3 in 2003 and 9.4% in 2010. The Chilean survey also shows a
clear parallel between prevalence of obesity and DM2 according to age groups (ENS, 2010).
The same as with obesity, DM2 is present in higher rates in people with less education and
socially more vulnerable groups, which confirms the close association with DM2. It also
increases with age, reaching figures close to 20% in elderly subjects.
Mortality for diabetes due to its chronic complications, particularly macrovascular complica‐
tions and especially coronary death, is among the 10 leading causes of death worldwide, and
the seventh cause of death in Chile. Diabetic patients exhibit 8 to 15 time higher frequency of
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cardiovascular disease (CVD) and 2 to 3 time higher cardiovascular disease mortality than the
general population. In the last 40 years, mortality for this cause has decreased in the general
population, but not in diabetics. In summary, coronary disease is the main cause of death in
DM2 and hyperglycemia is a direct mortality risk factor.
From the above the strong association between obesity, metabolic syndrome and DM2 can be
derived, which have common pathogenic mechanisms. It is widely accepted that for preven‐
tion of these three pathologies, the main control measures are similar: a healthy diet and
increased physical activity.
2. Prevention of DM
It is well known that dietary strategies are needed in order to prevent the onset and control of
DM2, at least 80% of the population with DM2 is obese, 75% suffers hypertension and
approximately 50% of DM2 patients are dislipidemic (mainly low high-density lipoprotein
cholesterol (HDL) and hypertriglyceridemia). General dietary prescriptions for both obese and
DM2 patients include well known diets of controlled calorie intake and predominant con‐
sumption of certain food groups like vegetables, legumes, fruits and nuts, whole-grain cereals,
olive oil, wine and fish.
Risk Prediction Factors for DM2. In 2007, the International Diabetes Federation (IDF)
published a consensus on DM2 prevention and defined non-modifiable and modifiable risk
factors (Alberti et al., 2007). Among the first are genetic factors, age - at an older age frequency
of DM2 is higher - and previous gestational diabetes (about 50% of women with a history of
gestational diabetes present DM2 10 years after delivery). Other non-modifiable risk factors
are low birth weight children (fetal undernutrition) and big for gestational age babies, who
frequently develop obesity as adults and, consequently, diabetes. The main individual
modifiable risk factor is obesity, particularly of the android type and, secondly, physical
inactivity. There is uncertainty regarding the influence of certain dietary factors, such as a
possible involvement of diets that are high in caloric content, saturated fatty acids and low in
unsaturated fatty acids and fiber.
Physiopathology of DM2. An important fact for being able to prevent a disease is the existence
of a long latency period, which allows the individual to take favorable actions. DM2 meets this
requirement, as it has a slow progression and is preceded by identifiable, reversible stages.
These begin with an insulin resistance (IR) state with compensatory insulin secretion sufficient
to maintain normoglycemia, with hyperinsulinemia values. Subsequently, there begins a
progressive fall in insulin levels, when the beta cell is no longer able to maintain hyperfunction,
and as insulin secretion deficiency begins, glycemia levels increasingly rise. Initially post-
prandial glucose is affected, and later fasting glucose, a state designated as “prediabetes”. If
no measures are taken, after approximately 10 years of the IR state, clinical DM2 develops.
Other physiopathological alterations in DM2 patients that are still under study are the
existence of an accelerated gastric emptying and defects in the regulation of feeding, which
may explain obesity of these patients.
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Search for individuals at risk for DM2. In 2007 international experts established the necessary
steps for preventing DM2, based on controlling the modifiable risk factors (Alberti et al., 2007).
They defined two groups, separating persons at high risk of developing DM2 from the rest of
individuals. Once the former have been identified, it is necessary to measure the risk level with
a score, in order to take the necessary actions. For identifying persons over 18 years with a
high risk for DM2, a questionnaire is applied which should include the following factors:
(android) obesity, age, family history of DM, cardiovascular and in women of gestational
diabetes, and the use of diabetogenic drugs (glucocorticoids, adrenergic beta antagonists,
thiazides and thyroid hormones). For a precise risk measurement, some models have been
proposed, such as the non-invasive, low cost Diabetes Risk Score by Lindström (Lindström &
Tuomihleto, 2003), which does not include laboratory tests.
To date, evaluation guidelines recommended by the international organizations to establish
with higher certainty a predictive score are still lacking, in order to mathematically select those
individuals with higher risk for DM; in the future, this will be a very useful tool. There is no
agreement regarding the search mode in children and adolescents, and the risk factors
employed are those established for adults: obesity, sedentarism, family history of DM and,
additionally, other factors pertaining to adolescents, such as the increase in growth hormone
during puberty and presence of polycystic ovary syndrome or hyperandrogenism; in children,
low birth weight and growth retardation could be important. A search mode for pregnant
women at risk for DM has not been internationally defined either.
The IDF (Alberti et al., 2007) establishes that once persons at risk for DM2 have been identified,
the recommendation is to determine fasting and post-load glycemias, which allow detecting
cases of glucose intolerance and non-diagnosed DM. In addition, in fasting glycemias ranging
between 110-125 mg/dl (impaired fasting glucose, as defined by the IFG), the recommendation
is to perform an Oral Glucose Tolerance Test (OGTT) with 75 g glucose. Those persons with
glycemia of 140-200 mg/dl are glucose intolerant (GI). Both states are designated as prediabetes
and, if no pharmacological and non-pharmacological measures are received, they will develop
DM2 in the short term.
2.1. Interventions for preventing or delaying DM2
Prevention with changes in lifestyle. Since the Malmö study, Sweden 1991, there exists
evidence demonstrating that changes in lifestyle may delay or prevent DM2, in prediabetic
individuals and in those at high risk of developing the disease, even if glycemias are normal.
Research carried out in different countries and mainly in Caucasian subjects (the Malmö study,
the Finnish Diabetes Prevention Study (DPS) and the US Diabetes Prevention Program (DPP,
2002), achieve similar results, with a decrease in the relative risk (RR) of developing DM2 of
63%, 58% and 58%, respectively (Table 1). Studies performed in Chinese individuals, in the
city of Da Qing, and in India, Indian Diabetes Prevention Program (IDPP), obtain a smaller
risk reduction, of 40% and 29%, respectively. The most remarkable conclusion is that for all
studied ethnic groups, it is possible to prevent DM2.
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STUDY
Country n
Years of follow-
up
Average age
(years)
Average BMI
(kg/m2)
↓Relative risk of
developing DM2
DA QING
China 577 6.0 45 25.6 40%
DPS
Finland 522 3.2 55 31 58%
DPP
USA 3234 2.8 51 34 58%
IDPP
India 531 3.0 45.4 25.8 29%
Table 1. Studies on DM2 prevention with lifestyle changes
The five studies discussed have in common that the groups submitted to intervention received
feeding advice for reducing weight, plans of structured physical exercise and periodic visits
from the medical team for controlling compliance of the indications; on the contrary, the
individuals who constituted control groups were only observed, without receiving any special
indications. The results of the follow-up of DPS (Lindström et al., 2006) after the end of the
three-year intervention period in subjects who had not developed diabetes are very interesting
to note, as a 43% reduction of the RR of incidence of DM2 was found. The authors believe that
the final success obtained in prediabetic patients is due to the fact that these individuals
permanently adopted a healthy lifestyle with greater physical activity, dietary changes and
weight loss.
The Da Qing study published similar results to the DPS in an observational study of up to 20
years. It showed a risk reduction of 43% in intolerant patients who were followed for up to 14
years after the end of the 6-year intervention period. The beneficial preventive effect for DM2
does not disappear at the end of the study period, but extends for many more years, probably
through permanent lifestyle modifications which were internalized by the individuals.
2.2. DM2 prevention with pharmacological measures
The success obtained in DM2 prevention with changes in lifestyle encouraged many research‐
ers to perform pharmacological interventions in glucose intolerant patients, especially with
pharmacological measures. In Table 2 we summarize findings from several reports on the use
of antidiabetic drugs, indicating the number of subjects involved, the years of intervention and
the results of these programs on lowering the RR of DM2.
The DPP study (2002) in which glucose intolerant individuals received the metformin but
without indications for a change in lifestyle had a much lower efficacy in preventing DM2
(31%), than that obtained with non-pharmacological measures (58%). Very similar achieve‐
ments were shown by the group with metformin of the IDPP, with the same design and
methodology as the previous work. In spite of the relatively modest results with the use of
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metformin, this insulin-sensitizing medicament is the drug of choice for the pharmacological
treatment of the prediabetes state, when additional high-risk factors exist. Presently, it is the
drug recommended by the ADA, due to its low side effects and proven therapeutic action.
There are lesser benefits obtained with acarbose in the STOP- NIDDM study with a 25%
decrease in RR, in addition to producing marked undesirable digestive side effects and
premature drop-out in 31% of the subjects, due to said cause. The use of glitazones is under
discussion: Troglitazone and Rosiglitazone have been withdrawn from the market due to
cardiovascular risk, and the future of Pioglitazone, used in the ACT NOW study, is uncertain.
Myths or realities in DM2 prevention. Consumption of coffee is widespread throughout the
world; it contains caffeine and magnesium which affect glucose metabolism; high coffee intake
has been related to lesser risk of DM2 in the USA, Europe and Japan. The phytochemicals in
coffee could have a positive effect in slowing down the development of DM2 (van Dam et al.,
2006). In Japanese individuals, it was found that consumption of green tea reduces the risk for
DM2; flavonoids from vegetables and fruit - also contained in green tea - have insulin activity
and increase the action of the hormone (Iso et al., 2006).
One possibility for preventing DM2 would be the administration of vitamins E and C, which
improve insulin sensitivity by inhibiting oxidative stress and inflammation, respectively.
Rizzo et al. (2008), in a controlled study in older men with IFG, found that daily intake of 1000
mg of vitamin E combined with 1000 UI of vitamin C for four weeks, decreased inflammation
and improved insulin action, by increasing non-oxidative glucose metabolism, glycemia,
insulinemia and lipids. It has been proposed that, due to their potential anti-inflammatory and
autoimmune effects, in humans calcium and vitamin D supplements would reduce the
incidence of type 1 diabetes and possibly of DM2 (Danescu et al., 2009). The above findings
open new prospects for the pharmacological or non-pharmacological prevention of DM2.
DM2 prevention in primary health care. The IDF in its consensus of 2007 (Alberti et al., 2007)
addresses this issue and states that “intervention for delaying or preventing diabetes will cause
an important reduction of its incidence, its complications and co-morbidities”, and recom‐
mends controlling the modifiable risk factors:
Study Drug n Years offollow-up
Average age
(years)
Average BMI
(kg/m2)
↓Relative risk of
developing DM2
DPP Metformin 3234 2.8 51 34 31%
STOP NIDDM Acarbose 682 3.3 55 31 25%
IDPP Metformin 531 3.0 46 25.8 26%
ACT NOW Pioglitazone 602 4.0 52.3 34.3 78%
Table 2. Studies on DM2 prevention with pharmacological interventions
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• - in the whole population and
• - in individuals at high risk of presenting DM2.
For prevention in the population, the IDF suggests to organize National Plans of Diabetes
Prevention, adapted to the cultural conditions of each country and supported by existing
organized social groups, which might start in nurseries, pre-schools and schools. Programs
must have a broad coverage and must be oriented to controlling the two main modifiable risk
factors, obesity and sedentarism with the purpose of therapeutic emphasis directed to changes
in lifestyle.
3. Dietary strategies for the control of diabetes
The goals of nutritional therapy for diabetes are to prevent and treat complications such as
cardiovascular disease, hypertension, nephropathy, obesity and dyslipidemia, and include
achieving and maintaining safe or normal blood glucose levels, a normal lipoprotein profile,
and an improvement of health through a change of food choices and increased physical
activity. A healthy and balanced diet should provide enough calories for daily energy
requirements, in order to reduce and/or maintain an acceptable body weight.
3.1. Metabolic control of DM2
It is necessary to know the degree of metabolic control in the type 2 diabetic patient in order
to make the proper decisions for his/her treatment (Redsalud, 2006). It has been shown that
there is a direct correlation between chronic hyperglycemia and damage to the patient's target
systems and organs. The main tests for metabolic control are: glycosylated hemoglobin A1c
(HbA1c) and glycemia.
HbA1c. It is currently the best control parameter of glycaemia and reports retrospectively, the
glycemia average for a period of 6 to 12 weeks. Two important studies, UKPDS and DCCT,
which demonstrated the relationship between metabolic control and appearance or aggrava‐
tion of microangiopathic complications, employed it as an indicator of the degree of metabolic
control. The goal of the treatment is to achieve HbA1c <7%, with individualized variations, the
recommendation being that the HbA1c levels should be “the closest to normal, with the least
risk of hypoglycemia for the patient”. The recommended frequency of check-ups is every 3
months. Considering the heterogeneity of the elderly, goals may be variable, with 7% in a
patient in good conditions, to 8.0 - 8.5 % in a patient with limited life expectations due to co-
morbidities or with scarce awareness of hypoglycemias.
Glycemia. All patients should be checked with periodic laboratory glycemias or glycemias
measured by capillary blood monitors in the clinic. In DM2 patients, this check-up should be
carried out every three months. The goals or targets required for pre-prandial and post-
prandial glycemias appear in Table 3. Capillary glycemias assessed by the patient through
self-monitoring are necessary only in DM2 patients on insulin treatment; the usefulness of self-
monitoring has not been demonstrated in DM2 patients with oral treatment.
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Glycosylated hemoglobin A1c < 7 %
Pre-prandial glycemias 70 - 130 mg/dl
Post-prandial glycemias 160 - 180 mg/dl
Table 3. Metabolic Goals
Target organ compromise
Retina. The fundus study should be performed at diagnosis of DM2. If normal, it should be
repeated annually; if altered, the patient should be referred to a specialist.
Renal compromise. Assessment of plasma creatinine and calculation of glomerular filtration
should be performed at diagnosis of DM2 and, if normal, should be repeated annually.
Determination of proteinuria is performed at diagnosis of DM2; if negative, a microalbumi‐
nuria test is requested. Urinary albumin excretion (UAE) is quantified with the albumin/
creatinine ratio in a random urine sample. UAE values between 30 and 300 mg/g should be
repeated; microalbuminuria is diagnosed when 2 out of 3 samples continue to be altered. If
the UAE values are <30 mg/g, the check-up can be performed annually.
Neuropathy and arteriosclerosis of the lower limbs. The clinical examination is conducted
with exploration of feet and testing of tactile and vibratory sensitivity, reflexes and peripheral
pulses. This examination is conducted at the patient's diagnosis; if no alterations exist, it should
be systematically repeated once a year. In this examination, it is advisable to include the
orthostatism test.
Detection and prevention of cardiovascular disease (CVD). DM in general is a risk factor for
CVD and DM2 is associated with other factors which form part of the pre-diabetic status and
which exert negative interrelations leading to a more precocious and severe CVD. Detection
and control of these factors forms part of the treatment of DM; the most important are arterial
hypertension and dyslipidemia.
Arterial hypertension. Diabetic patients have a high risk of CVD starting from the pre-
hypertension stage, which also contributes to microvascular damage. Its optimized treatment
reduces micro- and macrovascular complications of DM. It is essential to guarantee detection,
control and treatment of hypertension. The goals to be achieved are < 130/ 80 mm Hg and, in
nephropaths, < 125/75 mm Hg.
Dyslipidemia. Lipid alterations are a known risk factor for CVD and are more aterogenic in
DM. The most important goal is to correct LDL cholesterol. Added to this is the so-called
“aterogenic” dyslipidemia of the diabetic and pre-diabetic patient: elevated triglycerides, low
HDL cholesterol and small, dense particles of LDL cholesterol. This explains why detection
and treatment of lipid alterations is a main part of the check-up and follow-up of DM2. Lipid
profiles should be included in the initial evaluation of DM2. If the result is normal, it should
be repeated once a year. The goals to be achieved are: triglycerides <150 mg/dl, HDL >40 mg/
dl in men, >50 in women and LDL <100 in primary CVD prevention and <70 in secondary CVD
prevention.
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With the aim of achieving an optimal metabolic control and prevention of micro- and macro‐
angiopathic complications, all patients should be encouraged to adhere to a healthy diet, low
in cholesterol and saturated fatty acids and high in dietary fiber. Additionally, regular physical
activity for 150 minutes per week, fractionated in 5 days, should be promoted.
3.2. Nutritional plan for DM2
Programmed diet (ADA, 2004) is one of the pillars of the treatment of DM2; without it, a proper
metabolic control is not achieved, and the patient should permanently adhere to it. In some
cases, together with exercise for some time, they both constitute sufficient total treatment for
the disease.
Nutritional requirements. Nutritional requirements of persons with diabetes are similar to
those of individuals without the disease. Calculation of total calories depends on the physical
activity and the nutritional status of the patient. For an estimation of daily calories, the factors
listed in Table 4 are used.
In overweight or obese individuals, a weight loss of 5-10% of the present weight improves
blood pressure and glycemic and lipid levels. Knowing the composition of the foods, the
ingredients of kitchen recipes and the amounts that should be eaten, it is possible to design
the dietary plan and apply the diet for the family group.
Nutritional status Physical activity
Sedentary Moderate Intense
Obese (BMI >30 kg/m²) 20-25 30 35
Overweight (BMI >25-29.9
kg/m²) 26-29 28 30
Normal (BMI 20-24-9 kg/m²) 30 35 40
Lean (BMI<20 kg/m²) 35 40 45-50
Table 4. Caloric recommendations for adults. Calories/ kg of acceptable body weight
Carbohydrates (CH). The percentage of carbohydrate calories varies, it is individual and based
on eating habits, targeted glycemia and lipids. The recommended range is between 55% and
60% of the total daily calories. Restriction of carbohydrates to less than 130 grams/day is not
recommended, since the brain and the nervous system have an absolute requirement for
glucose as a source of energy. In the dietary plan, it is advisable to leave out simple sugars
(honey, panela, molasses, sugar) or lower them in well-controlled patients to <5 g per day.
Lipids. In the type 2 diabetic patient, elevations in very low density lipoprotein (VLDL)
concentrations, reductions in high density lipoprotein (HDL) concentrations and elevations in
the low density fraction (LDL) may be found. Type 2 diabetics may have an altered lipid profile,
notwithstanding a good glycemic control.
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The main goal in lipid intake is to reduce consumption of saturated fatty acids and trans fatty
acids. Lipids should account for less than 30% of the total daily caloric intake. Foods containing
monounsaturated and polyunsaturated fatty acids should be preferred in order to comply with
the recommendations. Less than 7% of the calories provided by saturated (SFA) and trans fatty
acids is recommended. SFAs are the main source of formation of LDL cholesterol and are found
in fatty meats, dairy products and eggs. Trans fatty acids are produced by hydrogenating
vegetable or fish oils in order to achieve a more solid texture.
Monounsaturated fatty acids (MFA) are recommended in a proportion of 13%, especially in
the cis configuration, as found in olive oil, sesame, nuts and peanuts. MFAs may be beneficial
in the control of blood lipids and of cardiovascular diseases. It is indicated that less than 10 %
of the calories should be provided by polyunsaturated fatty acids (PFA), which are found in
vegetable oils such as corn, sunflower, safflower and soybean oils. Omega 3 eicosapentenoic
and docosahexenoic fatty acids (EPA and DHA) present in fish have a beneficial effect on
triglycerides. It is recommended not to exceed an intake of 200 mg of cholesterol per day.
Consumption of fish or fish oil containing omega-3 polyunsaturated fatty acids (PUFAs)
reduce the risk of coronary heart disease, decrease mild hypertension, prevent certain cardiac
arrhythmia and lower the incidence of diabetes. Omega-3 PUFAs play a vital role in the
development and function of the nervous system and photoreception. Dietary lipids should
be lowered if weight loss is desired; if this dietary scheme is maintained for a long term, it
contributes to weight loss and to ameliorate dyslipidemia.
The recommended lipid composition in the diet of a type 2 diabetic patient is set forth in Table 5.
< 7% of the calories: saturated (SFA) and trans fatty acids
<10% of the calories: polyunsaturated fatty acids (PFA)
13% of the calories: monounsaturated fatty acids (MFA)
Omega 3 fatty acids (cis configuration) 0.15 g/day
Table 5. Contribution of dietary fatty acids in a DM2 patient
Proteins. Proteins should account for 15-20 % of total caloric intake, 0.8 – 1.0 g/Kg of body
weight; dietary protein intake must be balanced and rich in essential amino acids. According
to the dietary guidelines, the intake of protein in the usual range does not appear to be
associated with the development of diabetic nephropathy, although it is advisable to avoid
intakes over 20 % of the total daily energy.
The Recommended Dietary Allowance (RDA) indications for the general population of 0.8 g
of proteins of high biological value, per kg of weight per day in the adult, are still followed.
Proteins of high biological value provide all of the essential amino acids and in the amounts
required by the body; they are the proteins of animal origin, all types of meat (beef, pork, fish,
etc), milk and eggs. When the drop in glomerular filtration is initiated, proteins should not be
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restricted beyond 0.6 g/kg/day in order not to cause malnutrition. In the highly uncompensated
type 2 diabetic patient, there could occasionally be a loss of body proteins.
Glycemic index. It is established as the incremental area under the glycemia curve produced
by the intake of a standard amount of available CHs of a food (usually 50 g), in relation to the
same amount of carbohydrates from a standard source (glucose or white bread). Recommen‐
dation is to prefer foods with low glycemic index (legumes, green vegetables).
Dietary fiber. Soluble fiber of vegetables, legumes and fruit (pectin) helps to control not only
glycemia but also lipids, and should be accompanied by an increase in water intake. Fibers
also help satiety. Processed foods tend to decrease the amount of available fiber. Complex
carbohydrates, which also have a high percentage of soluble dietary fiber, are present in
legumes, vegetables and fruits, and should be included in a healthy diet.
Sweeteners. Non-caloric sweeteners such as saccharin, aspartame, acesulfame K, sucralose,
estevioside are accepted as safe, as long as their accepted daily intake is observed.
Sodium. Individuals differ in sensitivity to sodium intake, related to arterial pressure. Sodium
recommendation is the same as for the general population: not more than 2.4 g/day, equivalent
to 6.0 g/day of NaCl.
Alcohol. The same recommendations as for the general population are valid. Never to drink
on an empty stomach and to prefer red wine due to its phenol (antioxidant) content; the
maximal recommended portion is not more than 2 cups per day in men and not more than one
in women. 100 ml of wine contain 9-13 g of alcohol, and one gram of alcohol provides 7 calories.
Alcohol abstention is recommended during pregnancy, in hypertriglyceridemia, pancreatitis,
arterial hypertension or neuropathy. If the individual with diabetes is abstemious, he/she will
be advised not to initiate this practice. Fruit and vegetable intake provides a suitable amount
of antioxidants.
Vitamins and Minerals. A suitable dietary intake provides vitamins and minerals in sufficient
amounts and no supplementation is necessary. However, there are some exceptions: individ‐
uals on chronic hypocaloric diets, which should be supplemented with iron and B-Complex
vitamins; iron, folate and calcium supplements are recommended to pregnant women; calcium
supplement is recommended to women with osteoporosis; and undernourished subjects are
advised to take supplements appropriate to the deficiency they present. Vitamin supplemen‐
tation with antioxidants (vitamins E, C and A) is not advisable as a routine, due to lack of
evidence and safety and long-term safety. Chromium, Selenium, Zinc and Manganese are
contained in the usual diet, while supplements are recommended only when patients have a
deficiency.
The nutritional plan detailed for DM2 is also recommended for individuals who are obese,
insulin-resistant, pre-diabetic and carriers of metabolic syndrome, in order to prevent them
from developing DM2.
To summarize, one of the key measures to achieve control targets in patients with diabetes is
a diet plan, as there is ample evidence that the goals are not achieved if patients fail non-
pharmacologic measures, diet and physical activity.
Control and Prevention of Obesity and Diabetes Type 2 Through Non-Pharmacological Treatments…
http://dx.doi.org/10.5772/56427
395
4. Nutrition and social behavior
The drastic and long-term changes in eating habits that are needed in order to prevent and
control these diseases require a highly motivated and educated population with the economic
means and a strong personal commitment to follow and maintain these indications. Changing
dietary habits may be a very difficult task to accomplish and constant support is needed from
health professionals who should develop individual therapeutic programs for each patient
according to their personal lifestyle requirements, tastes or cultural backgrounds.
Why is it so difficult to achieve this change to healthy eating habits? In the first place it is
important to understand that eating is not an isolated behavior, as in all societies it is part of
the cultural context that defines what is considered edible or appropriate (or not) for each
member of any particular group. Contreras & Grace (2005) suggest the presence of a food
culture that accompanies any food system, which is defined as follows: "the set of represen‐
tations, beliefs, knowledge and practices inherited and / or learned that are associated to food
and that are shared by individuals of a given culture or a social group within a culture". In
addition to keeping alive and avoiding overt hunger, food all over the world and in all possible
settings is also used to keep and classify human relationships, indicate social status, enhance
political, business and economic relations, provide praise and punishment, prevent and treat
physical and mental disease, to indicate religious adherence or membership, to evidence
emotions and even morals. As illustrated above, the underlying development of attitudes, from
infancy to old age, in pregnancy and disease, for adolescents and adults influence food
behavior and are determined by culture, economics, food technology, politics, the family and
recently, by mass media. Consequently, to achieve significant impact, education in nutrition
and dietetics also requires knowledge of the socio-cultural aspects of eating as well as its basic
scientific aspects, and the professional providing nutrition services and education in the
community needs an understanding of these facts (Bass et al., 1979). Briefly, food and food
consumption patterns underlie the social fabric in all societies and hence its cultural impor‐
tance cannot be underestimated.
Second, the social act of eating has changed along the millennia of humankind; therefore it is
of use to put the nutritional transitions into a historical context. From a long history of
omnivorism of hunter-gatherers (mainly plants supplemented with occasional meat), that
shaped our physiology to the present day, humans have moved through several important
transitions in their nutrition. Omnivorism probably required cooperation between members
of a species that is rather ill-equipped compared to other predators, possibly setting the stage
for social patterns for providing and distributing food (Aguirre, 2010). These conditions
selected among our ancestors those individuals endowed with genes that permitted the
accumulation of calories in times of surplus, and survive in times of low access to food or
starvation (Aguirre, 2010).
Later, approximately 15.000 to 10.000 B.P. a major nutritional transition occurs as an adaptation
to the higher temperatures of the postglacial era (and the associated decrease of large prey for
hunting) which leads to the development of agriculture (Smith & Munro, 2009). The intro‐
duction of staple food lead to the establishment of villages and an increase of the human
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population and a shift to meals based on cereals (i.e. carbohydrates) and a decrease of protein
intake. As a result, on a global scale humans on average became approximately 20 cm shorter
with a decreased life expectancy due to chronic malnutrition of micronutrients. Also, specific
diseases related to agricultural labor and food processing appeared, such as arthritis, skeleton
deformities and dental abrasion, particularly in women (Aguirre, 2010). The establishment of
sedentary societies also set the stage for classes with differential foods, creating small well-fed
upper classes with large, fat bodies and a majority of the population with the short and lean
phenotype of poverty, fed a low variety of (or a single) cereal or tuber staple (Aguirre, 2010).
The next nutritional transition comes about with the industrial revolution, which initially
causes a severe drop in the quality of life for the large majority of the population in the western
world. The new technologies completely change the methods of producing, distributing and
consuming foods. The modern relocation of edible plants throughout the world introduces the
concept of plantations, and worldwide distribution of some edible products such as sugar,
coffee, tea and potatoes, among others (Aguirre, 2010). The economic powers involved provoke
colonial wars, and in the long run, create the industrial food production with large scale food
transportation and storage, a panoply of additives (flavorings or dyes) and stabilizers, and the
disappearance of seasonality of fruits and vegetables and local food production, that charac‐
terizes the modern food production of in our days.
The genetic makeup of our species has not changed at the pace of these nutritional transitions,
so we are now faced with a large population, living in a largely industrial-urban setting that
still maintains those biological features that constituted an advantage for survival in the past.
Although there are 870 millions of people suffering hunger today (http://faostat3.fao.org/
home/index.html), for the first time in human history, a large segment of the population has
access to a large supply of calories in the form of carbohydrates and fats, albeit, not to a healthy
diet with low fat proteins and micronutrients. Finally, this nutritional transition has happened
so fast that the shift from undernourishment to obesity has occurred within just two genera‐
tions. Indeed, in developing countries, it is not uncommon that an individual, who experienced
undernourishment during childhood, is today an obese adult with overweight children.
Therefore, in a completely different context, our genetic makeup in an era of surplus calories
and changing lifestyles provides the basis for the worldwide epidemic of obesity and diabetes.
As pointed out at the beginning of this section, a highly motivated and educated popula‐
tion with the economic means and a strong personal commitment to follow and maintain
the indications is needed to revert this situation. Low levels of education of mothers also
tend to result in children that spent more time watching TV and eat a higher amount of
fat  and  calorie-rich  snacks  and  “junk  food”,  highlighting  the  importance  of  enhancing
school-based and community-based actions to promote healthy eating and physical activi‐
ty addressed to children and young people (Aranceta et al., 2003). Also, in the face of in‐
creasing food prices, many people with lower incomes do not have a realistic possibility
of choosing an appropriate diet.
Since the general population in most developing countries such as Chile, is not able to keep
these recommendations in the long term for any of the above reasons, several kinds of dietary
interventions have been proposed. These include low calorie foods and foods containing high-
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quality ingredients such as peptides derived from fish. Some of these strategies include the
replacement of red meat and its derivatives by fish and white meat, the reduction of the total
fat intake (saturated fat) and replacement by the use of other oils (such as olive oil) and a higher
intake of dietary fiber, replacing white bread with whole grain bread. Here we propose to
include marine-derived proteins, specifically fish-derived protein hydrolysates as high
biological value proteins of low cost as dietary supplements or ingredients, as a means of
preventing obesity and diabetes.
5. Marine-derived protein
5.1. General aspects
Seafood and fish are sources of high biological value proteins, unsaturated essential fatty acids,
vitamins and antioxidants, minerals or trace metals and physiological beneficial amino acids
and peptides. Additional components in seafood may be of importance for the development
of life style diseases like coronary heart disease. There is ample literature on marine-derived
peptides (salmon and other fish) with biological activity against obesity, DM2 and cardiovas‐
cular disease, which leads to the proposal of using protein concentrates produced by enzymatic
hydrolysis from co-products of the fish industry that may contain these peptides. Several
research groups, including ourselves, are concentrated on generating an application or
nutraceutical biological functionality of these products.
Different  strategies  have  been  studied for  recovering  protein  from the  marine  products
industry,  as  for  example  fish  protein  hydrolysates  (FPHs,  by  its  acronym  in  English).
These  treatments  are  obtained by solubilizing the  raw protein,  via  peptide  bond breaks
which release smaller peptides and free amino acids, that can then be separated and re‐
covered.  In this  type of  application protein recovery by enzymatic hydrolysis  is  chosen,
because this treatment gives rise to a final product of higher digestibility than untreated
protein (Aurrekoetxea & Perera, 2002).
Several  studies  reveal  that  proteins  derived  from hydrolysis  of  marine  products  are  of
high  nutritional  value,  rich  in  essential  amino  acids  and  even  similar  to  proteins  from
beef (Kristinsson & Rasco, 2000). It has also been observed that hydrolysates, treated with
commercial  enzymes,  exhibit  functional  characteristics  (solubility,  fat  absorption,  water
absorption  and  stability  of  the  emulsion)  consistent  with  potential  uses  as  emulsifying
agents, and absorbing agents, being potentially competitive with existing protein hydroly‐
sates, such as dairy products and vegetables, which are currently available on the market
(Sathivel et al., 2005).
Enzymatic digestion of proteins of marine origin results in FPH. Among the problems of
obtaining the FPH, is the extreme susceptibility to oxidation of fats, and the presence of these
oil residues which generate unpleasant odors and flavors from an organoleptic viewpoint
(Hoyle & Merritt, 1994).
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Protein hydrolysates also have non-food applications such as power supply for the growth of
microorganisms such as yeast hydrolysates or casein. They can also be used eventually as plant
fertilizers and also used in cosmetics for hair treatment (due to its suggested effect of strength‐
ening of hair) (Vioque & Millan, 2005).
Enzymatic hydrolysis has clear advantages over traditional acid or alkaline chemical hydrol‐
ysis, for the following reasons (Guadix et al., 2000):
• Selectivity. Enzymes are specific for a particular type of chemical bond, and the appearance
of degradation products is not common. In contrast, the low selectivity of the acidic and
basic treatments inevitably leads to the appearance of degradation products that are difficult
to control and may be toxic.
• Moderate temperature and pH conditions. Enzymatic hydrolysis generally proceeds in the
range of 40 to 60°C and pH of 4.0 to 8.0.
• No foreign substances are added. Chemical hydrolysis processes are carried out with strong
acids or bases, which are then neutralized, thereby significantly raising the salt content of
the product.
• Maintain the nutritional value. There is no degradation of the components, while alkaline
hydrolysis destroys the amino acids arginine and cysteine, and acid hydrolysis removes
tryptophan and deaminates serine and threonine.
As a result of biological hydrolysis, high-protein, low-fat FPHs can be obtained, which are
completely soluble products (Aurrekoetxea & Perera, 2002).
5.2. Physiological effects of marine-derived peptides and aminoacids
Potent peptides with high anti-hypertensive activities (inhibitors of angiotensin I-converting
enzyme or ACE) and peptides which may modulate central neuropeptide levels have been
isolated from fish hydrolysates (Yoshikawa et al., 2000; Sorensen et al., 2004). Marine low
molecular weight components antioxidants (tocopherols, CoQ10, selenium, taurine) have
attracted special attention due to their possible prevention of low-density lipoprotein (LDL)
oxidation. Fish proteins have also been shown to inhibit LDL oxidation in rat models (Kondo
et al., 2000).
It has been documented that peptides obtained from fish muscle digests possess potent
inhibitory activity against ACE and antihypertensive properties (Galardy et al., 1984; Kohama
et al., 1996). For assessment of relative antihypertensive activities of two peptides (LKPNM
and LKP) derived from bonito fish to that of captopril, administered orally to SHR rats to
monitor time-course changes of blood pressures (Fujita & Yoshikawa, 1999). Both LKPNM and
captopril showed maximal decrease of blood pressure 4 h after oral administration and their
efficacies lasted until 6 h post-administration. In sharp contrast, however, maximal reduction
of blood pressure occurred as early as 2 h after administration of LKP. When compared on
molar basis, antihypertensive activities of LKPNM and LKP accounted for 66% and 91%
relative to that of captopril, respectively, whereas in vitro ACE-inhibitory activities of LKPNM
and LKP were very low compared with that of captopril. It is of interest to note that both of
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these peptides exerted remarkably higher antihypertensive activities in vivo despite weaker
in vitro ACE-inhibitory effects, using captopril as the reference drug (Fujita & Yoshikawa,
1999). Such peptides may be regarded as healthy components (through endogenous metabo‐
lism) of fish muscles and additionally may be produced as ingredients or diet supplements.
Amino acids (taurine) and peptides (ACE -inhibitors) are beneficial components from seafood
and hence components in possible ingredients in functional foods. Seafood contains high levels
of the amino acid taurine and the consumption of seafood has been shown to increase its serum
concentration (Laidlaw et al., 1990; Kim et al., 1996). The suggestion of a possible association
between fish intake and reduced cardiovascular risk through the beneficial effects of proteins
and taurine, in addition to omega n-3 fatty acids, has been put forward (Mizushima et al., 1997;
Yamori et al., 1994).
In humans, taurine is regarded to be a conditionally essential amino acid, as its physiological
concentration can be partly regulated endogenously. Taurine is known to have several positive
effects on the cardiovascular system, as described in a broad review by Niittynen et al. (1999).
Firstly, taurine has antioxidant activity. This may reduce the production of proinflammatory
products. Secondly, taurine has been shown to lower blood pressure in borderline hyperten‐
sive patients. It has also been reported that taurine can improve cardiac performance, reduce
blood cholesterol values and suppress platelet aggregation (Niittynen et al., 1999). A protective
role from both taurine and ACE inhibitors has been found in age-related progressive renal
sclerosis in 24 and 30 months old rats. Taking into account the antioxidant properties of taurine,
these data suggest a role for ROS in age-related progressive renal fibrosis, perhaps through
interactions with de TGF-β1 pathway (Iglesias-de la Cruz et al., 2000). Although commonly
used as a dietary supplement in the Far East, the potential advantages of dietary taurine
consumption /supplementation have not been recognized in the Western World (Stapleton et
al., 1998).
Frozen-preserved commercial diets have been shown to maintain plasma taurine concentra‐
tion, whereas the heat-processed diets do not (Kim et al., 1996; Dragnes et al., 2009). On the
other hand, a significant correlation was found between the results of the biological assessment
of the nutritional value of processed protein and of taurine content in the liver and urine of
rats (Lipka et al., 1993).
5.3. Improvement of FPHs through the use of enzymes
The functional properties of FPHs can be improved by the use of specific enzymes and by the
choice of the hydrolysis conditions, such as time, temperature and pH. In this way partial
hydrolysis can be achieved. There are a number of different commercial proteolytic enzymes
that can be used to produce hydrolysates (Liceaga-Gesualdo & Li-Chan, 1999).
The addition of exogenous enzymes to the hydrolytic process makes it more controllable and
reproducible. Consequently, different commercial proteolytic enzymes have been tested on a
variety of marine substrates. The preferred commercial enzymes are proteases of bacterial
origin, such as Alcalase, Neutrase, Protamex (bacterial proteases trade names), but also the
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plant proteases such as papain (commercially called Corolase L-10), present good yields in
hydrolytic processes (Aspmo, 2005).
All enzymes used for hydrolyzing proteins of marine origin have to be of food grade, and if
they are of bacterial origin, the production organism needs to be non-pathogenic. The choice
of enzyme is usually determined by a combination of effectiveness and economy (Kristinsson
& Rasco, 2000). Major factors in the choice of enzymes are the organoleptic and functional
characteristics of the final food product.
5.4. Organoleptic properties of the hydrolysate
Although enzymatic hydrolysis of marine proteins produces peptides with desirable func‐
tional properties, it has the disadvantage of generating bitterness. This is a common problem
with FPHs, and is the main reason for its low acceptance as a food ingredient. The mechanism
for the development of bitterness is not yet clear, but it is widely accepted that the hydrophobic
amino acids of the peptides are the main factor. The hydrolysis of proteins results in the
exposure of internal hydrophobic peptides which are able to interact rapidly with the taste
buds, resulting in the detection of bitter taste. However, extensive hydrolysis to produce free
amino acids reduces the bitterness of peptides, because hydrophobic peptides are much
bitterer compared with a blend of free amino acids, which are though, undesirable from a
functional point of view. A strict control of the degree of hydrolysis in any experimental system
is therefore desirable to prevent the development of bitter taste and also for the retention of
functional properties (Kristinsson & Rasco, 2000; Liaset et al., 2003; Benitez et al., 2008).
Proteases have different specificity for the amino acids they cut, so the choice of the most
appropriate enzyme or mixture of enzymes depends on the raw material subjected to hydrol‐
ysis, and may affect the degree of bitterness. For instance, enzymes with a high preference for
hydrophobic amino acids, such as Alcalase, are often preferred and may yield products with
low bitterness. The use of exopeptidases, instead of endoproteases, may also be useful in
reducing the bitterness of the FPH, particularly if exopeptidases separating hydrophobic
amino acids from bitter peptides are used. However, for an enzyme preparation to be effective
in protein hydrolysis, both exopeptidases and endopeptidases are required. Many studies have
shown that preparations containing proteolytic exopeptidases and endopeptidases produce
less bitter peptides than single proteases. The addition of exopeptidases to the process often
eliminates the bitter taste of the hydrolysates (FitzGerald & O`Cuinn, 2006).
The ideal method for the quantification of the bitterness of a hydrolysate is the use of a sensory
evaluation panel. This is a time-consuming activity and requires an appropriate number of
panelists trained to detect such bitterness, in order to obtain statistically relevant data (Fitz‐
Gerald & O`Cuinn, 2006; Seo et al., 2008).
5.5. Use of antioxidants in the hydrolysis
Oils and fatty products generally undergo oxidation during production and storage. A major
problem of the preparation of FPHs is their extreme susceptibility to such oxidation fats (Hoyle
& Merritt, 1994). This oxidation process in food causes a sequence of unfavorable changes,
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consisting mainly in deterioration of the sensory properties of the product such as rancidity,
changes in color and texture and reduced nutritional value. It also increases health risks, along
with economic losses and may even influence the development of bitter flavors (Palić & Lucan,
1995; Valenzuela et al., 2003; Gramza & Korczak, 2005; Mendis et al., 2005; Dong et al., 2008).
Marine oils are rich in polyunsaturated fatty acids (PUFAs), especially of the ω3 family such
as EPA and DHA, however diets containing these oils are more susceptible to oxidation than
those containing other types of oils, because of their high concentrations of long chain PUFAs;
the aforementioned examples are DHA and EPA (Gonzalez et al., 1992; Fritsche & Johnston,
1988; Wanasundara & Shahidi, 1998).
PUFA degradation via chain reaction mechanisms of free radicals, results in changes of smell
and taste (rancidity) of edible oils and oil-containing foods. The chemical reactions involved
in oxidative processes require low activation energy, and do not significantly change their
ranges at low storage temperatures; therefore, it is necessary to delay the onset of oxidation of
the marine oil to maintain its flavor and odor (Wanasundara & Shahidi, 1998; Ahn et al., 2007).
5.6. Antioxidants
Antioxidants, natural and synthetic, are commonly used by the food processing industry, to
prolong the storage stability of food. The main commonly used synthetic antioxidants are
butylhydroxybutilanisol, butylated hydroxytoluene, propyl gallate and tertiary butylhydro‐
quinone (BHA, BHT, PG and TBHQ, respectively, for their acronyms in English). Natural
antioxidants such as tocopherols, rosemary extracts (Herbalox, commercial product) and
ascorbic acid are often preferred (Gramza & Korczak, 2005; Yu et al., 2006).
5.7. Preliminary trials
Preliminary tests of the organoleptic properties of enzymatic hydrolysis of marine proteins
with different commercial enzymes, among them Alcalase, and Colorasa Protamex (papain)
and different commercial antioxidants, showed greater acceptability of the process than with
the protease Colorasa L-10. These results were observed after organoleptic analysis of the
obtained products in trials with healthy volunteers (unpublished results).
While the use of antioxidants improves the stability of the oil fraction obtained together with
the protein fraction, products derived from an antioxidant-free process were more acceptable
(organoleptic properties) than those obtained in a process in which antioxidants were are used,
although the oil fraction underwent faster oxidation (unpublished results). These results
suggest that the addition of antioxidants is not of vital importance in the course of an organo‐
leptically suitable product with a high proportion of proteins of marine origin.
6. Concluding comments
In this chapter we present general data concerning the worldwide epidemic of obesity and
diabetes and discuss the present day goals of metabolic control of affected patients. The current
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strategies used for prevention of the development of prediabetes and diabetes are discussed
and a brief up-to-date review of summarizes the dietary strategies for the nutrition of diabetic
patients.
In the following section we briefly describe the main impact of historic nutritional transitions
and illustrate how the social impact of present day food production, distribution and con‐
sumption is exacting a high toll on public health (and also on the environment). To amend this
general pattern, large changes of society on a global scale are needed. Since these do not seem
realistic in the short term, alternative strategies to address particular problems are suggested,
such as nutritional intervention with high quality nutrients of low economic value such as
supplementing foods with marine-derived protein hydrolysates.
A discussion of the different procedures for obtaining fish derived protein hydrolysates is
presented, centered on the advantages of enzymatic hydrolysis, with respect to chemical
procedures. The use of antioxidants during the hydrolysis process is also analyzed and not
found to be essential for obtaining a high quality product. The organoleptic properties of
hydrolysates obtained by our group have proven acceptable in trials to healthy volunteers. In
addition, fish derived protein hydrolysates may contain peptides and/or aminoacids which
may bear additional beneficial effect.
To summarize, healthy dietary habits are part of the necessary lifestyle to prevent obesity and
DM2; an increased intake of marine products is also recommended as a means to control risk
factors of cardiovascular disease of DM2 patients.
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